Home » Topics » Regulatory

Regulatory
RSS

FDA approves Piqray for HR+/HER2-, PIK3CA-mutated advanced breast cancer

May 27, 2019

Jakafi approved by FDA for steroid-refractory acute GvHD

May 27, 2019

FDA approves Zolgensma for spinal muscular atrophy

May 27, 2019

Actemra approved in Japan for adult-onset Still's disease

May 23, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

FDA approves Bavencio with Inlyta for advanced renal cell carcinoma

May 15, 2019

FDA approves Eylea to treat all stages of diabetic retinopathy

May 14, 2019

FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib

May 13, 2019

Waylivra receives conditional marketing authorization from the European Commission

May 8, 2019

FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome

May 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...